The use of HPLC with electrochemical detection to monitor reactive oxygen and nitrogen species, markers of oxidative damage and antioxidants - application to the neurosciences, I.N. Acworth et al; monitoring of excitotoxicity in neurologic disorders, G.A. Qureshi; oxidative damage - an early and central event in the pathogenesis of Alzheimer disease, G. Perry, M.A. Smith; multiple cerebral infarction in rats - pathological and pathophysiological studies, H. Saito et al; prospects of recombinase-mediated HPRT gene therapy for Lesch-Nyhan disease, R. Bertolotti; opioid peptides in drug dependence and neurological diseases, I. Nylander, J. Silberring; alcoholic intoxication, J. Nikoli; amphetamine neurotoxicity - roles for dopamine, glutamate and oxidative stress, B.K. Yamamoto et al; identification of emesis induced by centrally acting drugs and anticancer drugs, M. Minami et al; vitamin B12 concentration as a marker of dementia, M. Minami et al; histamine, K. Maeyama, T. Watanabe; abnormal tryptophan metabolism, neurologic/psychiatric disturbances and its relationship to immune activation, T. Gasse et al; acetylcholine, catecholamine, indolamine and GABA levels in the brain of rats submitted to a convulsant, T.K. Hevor et al; analysis of salsolinols, endogenous neurotoxins, in human materials, M. Naoi et al; polymines and related compounds as markers of physiopathology and cell differentiation - analytical methods, V.R. Villanueva; monoamine oxidase neurotoxicity and methodology, A. Nicotra, S.H. Parvez; dynorphin converting enzymes and strategies for their characterization, J. Silberging; apoliprotein E in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease, R.A.J. Esselink et al; classical neurotransmitters and their correlation with neuropeptides in cerebrospinal fluid of patients with neurological disorders, G. Ali Qureshi; cerebrospinal fluid markers of HIV-1 infection, M. Gisslen; brain lipid levels in neurodegenerative disorders, M. Spderberg, P.J. Sindelar; novel fluorometry of norsalsolinol - an endogenous 1,2,3,4-tetrahydro-6,7-dihydroxysoquinoline from dopamine, M. Yoshioka et al; biopterin and neopterin as neurochemical markers of neurological disease, H. Kuzuya et al; neuropeptide analysis in human pituitary tumours, X. Zhu, D.M. Desiderio; studies on neuronal apoptosis using a COMET assay and cultured cells, W. Maryyama, M. Maoi; three dimensional HPLC-EC analyses of regional brain neurotransmitter disturbances in Alzheimer's disease with and without Lewy bodies, P.J. Langlais. (Part contents).
